/
Am J Hematol
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome
- P. Le Coutre
- K.A. Kreuzer
- I.K. Na
- M. Schwarz
- J. Lupberger
- M. Holdhoff
- G. Baskaynak
- H. Gschaidmeier
- U. Platzbecker
- G. Ehninger
- W. Prejzner
- D. Huhn
- C.A. Schmidt